A Combined Shotgun and Targeted Mass Spectrometry Strategy for Breast Cancer Biomarker Discovery

Journal of Proteome Research

Volumn 14, Issue 7, 2015, Pages 2807-2818

  Sjöström, Martin ^a   Ossola, Reto ^a,g   Breslin, Thomas ^a   Rinner, Oliver ^b   Malmström, Lars ^c   Schmidt, Alexander ^c   Aebersold, Ruedi ^d   Malmström, Johan ^e   Niméus, Emma ^f  

^a LUND UNIVERSITY   (Sweden)

^b Biognosys AG   (Switzerland)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d UNIVERSITY OF BASEL   (Switzerland)

^e ETH ZURICH   (Switzerland)

^f LUND UNIVERSITY HOSPITAL   (Sweden)

^g GENEDATA AG   (Switzerland)

Author keywords

biomarker; breast cancer; estrogen receptor; HER2; LC MS MS; MRM; N glycosylation; shotgun proteomics; SRM; targeted proteomics

Indexed keywords

BIOLOGICAL MARKER; ESTROGEN RECEPTOR; GLYCOPEPTIDE; PROTEOME; TUMOR MARKER;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; BREAST CANCER; CANCER PROGNOSIS; CANCER RECURRENCE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; MEASUREMENT ACCURACY; METASTASIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY; VALIDATION STUDY; BREAST NEOPLASMS; PROCEDURES;

BIOMARKERS, TUMOR; BREAST NEOPLASMS; FEMALE; HUMANS; TANDEM MASS SPECTROMETRY;

EID: 84939840284     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/acs.jproteome.5b00315     Document Type: Article

References (72)

1. Youlden, D. R.; Cramb, S. M.; Dunn, N. A.; Muller, J. M.; Pyke, C. M.; Baade, P. D. The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality Cancer Epidemiol. 2012, 36 (3) 237-248
2. Perou, C. M.; Sorlie, T.; Eisen, M. B.; van de Rijn, M.; Jeffrey, S. S.; Rees, C. A.; Pollack, J. R.; Ross, D. T.; Johnsen, H.; Akslen, L. A.; Fluge, O.; Pergamenschikov, A.; Williams, C.; Zhu, S. X.; Lonning, P. E.; Borresen-Dale, A. L.; Brown, P. O.; Botstein, D. Molecular portraits of human breast tumours Nature 2000, 406 (6797) 747-752
3. Sorlie, T.; Perou, C. M.; Tibshirani, R.; Aas, T.; Geisler, S.; Johnsen, H.; Hastie, T.; Eisen, M. B.; van de Rijn, M.; Jeffrey, S. S.; Thorsen, T.; Quist, H.; Matese, J. C.; Brown, P. O.; Botstein, D.; Lonning, P. E.; Borresen-Dale, A. L. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc. Natl. Acad. Sci. U. S. A. 2001, 98 (19) 10869-10874
4. Gruvberger, S.; Ringner, M.; Chen, Y.; Panavally, S.; Saal, L. H.; Borg, A.; Ferno, M.; Peterson, C.; Meltzer, P. S. Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns Cancer Res. 2001, 61 (16) 5979-5984
5. Andre, F.; Pusztai, L. Molecular classification of breast cancer: implications for selection of adjuvant chemotherapy Nat. Clin. Pract. Oncol. 2006, 3 (11) 621-632
6. Iqbal, N.; Iqbal, N. Human Epidermal Growth Factor Receptor 2 (HER2) in Cancers: Overexpression and Therapeutic Implications Mol. Biol. Int. 2014, 2014, 852748
7. Weigelt, B.; Peterse, J. L.; van t Veer, L. J. Breast cancer metastasis: markers and models Nat. Rev. Cancer 2005, 5 (8) 591-602
8. Sparano, J. A.; Paik, S. Development of the 21-gene assay and its application in clinical practice and clinical trials J. Clin. Oncol. 2008, 26 (5) 721-728
9. Cardoso, F.; Vant Veer, L.; Rutgers, E.; Loi, S.; Mook, S.; Piccart-Gebhart, M. J. Clinical application of the 70-gene profile: the MINDACT trial J. Clin. Oncol. 2008, 26 (5) 729-735
10. Gygi, S. P.; Rochon, Y.; Franza, B. R.; Aebersold, R. Correlation between protein and mRNA abundance in yeast Mol. Cell. Biol. 1999, 19 (3) 1720-1730
11. Ginestier, C.; Charafe-Jauffret, E.; Bertucci, F.; Eisinger, F.; Geneix, J.; Bechlian, D.; Conte, N.; Adelaide, J.; Toiron, Y.; Nguyen, C.; Viens, P.; Mozziconacci, M. J.; Houlgatte, R.; Birnbaum, D.; Jacquemier, J. Distinct and complementary information provided by use of tissue and DNA microarrays in the study of breast tumor markers Am. J. Pathol. 2002, 161 (4) 1223-1233
12. Anderson, L.; Seilhamer, J. A comparison of selected mRNA and protein abundances in human liver Electrophoresis 1997, 18 (3-4) 533-537
13. Mann, M.; Jensen, O. N. Proteomic analysis of post-translational modifications Nat. Biotechnol. 2003, 21 (3) 255-261
14. Olsson, N.; Carlsson, P.; James, P.; Hansson, K.; Waldemarson, S.; Malmstrom, P.; Ferno, M.; Ryden, L.; Wingren, C.; Borrebaeck, C. A. Grading breast cancer tissues using molecular portraits Mol. Cell Proteomics 2013, 12 (12) 3612-3623
15. Liu, N. Q.; Stingl, C.; Look, M. P.; Smid, M.; Braakman, R. B.; De Marchi, T.; Sieuwerts, A. M.; Span, P. N.; Sweep, F. C.; Linderholm, B. K.; Mangia, A.; Paradiso, A.; Dirix, L. Y.; Van Laere, S. J.; Luider, T. M.; Martens, J. W.; Foekens, J. A.; Umar, A. Comparative Proteome Analysis Revealing an 11-Protein Signature for Aggressive Triple-Negative Breast Cancer J. Natl. Cancer Inst. 2014, 106 (2) djt376 10.1093/jnci/djt376
16. Zielinska, D. F.; Gnad, F.; Wisniewski, J. R.; Mann, M. Precision mapping of an in vivo N-glycoproteome reveals rigid topological and sequence constraints Cell 2010, 141 (5) 897-907
17. Tian, Y.; Zhang, H. Characterization of disease-associated N-linked glycoproteins Proteomics 2013, 13 (3-4) 504-511
18. Goncalves, A.; Bertucci, F. Clinical application of proteomics in breast cancer: State of the art and perspectives Med. Princ. Pract. 2011, 20 (1) 4-18
19. Teleman, J.; Karlsson, C.; Waldemarson, S.; Hansson, K.; James, P.; Malmstrom, J.; Levander, F. Automated selected reaction monitoring software for accurate label-free protein quantification J. Proteome Res. 2012, 11 (7) 3766-3773
20. Sutton, C. W.; Rustogi, N.; Gurkan, C.; Scally, A.; Loizidou, M. A.; Hadjisavvas, A.; Kyriacou, K. Quantitative proteomic profiling of matched normal and tumor breast tissues J. Proteome Res. 2010, 9 (8) 3891-3902
21. Gong, Y.; Wang, N.; Wu, F.; Cass, C. E.; Damaraju, S.; Mackey, J. R.; Li, L. Proteome profile of human breast cancer tissue generated by LC-ESI-MS/MS combined with sequential protein precipitation and solubilization J. Proteome Res. 2008, 7 (8) 3583-3590
22. Deng, S. S.; Xing, T. Y.; Zhou, H. Y.; Xiong, R. H.; Lu, Y. G.; Wen, B.; Liu, S. Q.; Yang, H. J. Comparative proteome analysis of breast cancer and adjacent normal breast tissues in human Genomics, Proteomics Bioinf. 2006, 4 (3) 165-172
23. Bouchal, P.; Roumeliotis, T.; Hrstka, R.; Nenutil, R.; Vojtesek, B.; Garbis, S. D. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis J. Proteome Res. 2009, 8 (1) 362-373
24. Leth-Larsen, R.; Lund, R.; Hansen, H. V.; Laenkholm, A. V.; Tarin, D.; Jensen, O. N.; Ditzel, H. J. Metastasis-related plasma membrane proteins of human breast cancer cells identified by comparative quantitative mass spectrometry Mol. Cell Proteomics 2009, 8 (6) 1436-1449
25. Makawita, S.; Diamandis, E. P. The bottleneck in the cancer biomarker pipeline and protein quantification through mass spectrometry-based approaches: current strategies for candidate verification Clin. Chem. 2010, 56 (2) 212-222
26. Boja, E.; Rivers, R.; Kinsinger, C.; Mesri, M.; Hiltke, T.; Rahbar, A.; Rodriguez, H. Restructuring proteomics through verification Biomarkers Med. 2010, 4 (6) 799-803
27. Paulovich, A. G.; Whiteaker, J. R.; Hoofnagle, A. N.; Wang, P. The interface between biomarker discovery and clinical validation: The tar pit of the protein biomarker pipeline Proteomics Clin. Appl. 2008, 2 (10-11) 1386-1402
28. Lange, V.; Picotti, P.; Domon, B.; Aebersold, R. Selected reaction monitoring for quantitative proteomics: a tutorial Mol. Syst. Biol. 2008, 4, 222
29. Whiteaker, J. R.; Lin, C.; Kennedy, J.; Hou, L.; Trute, M.; Sokal, I.; Yan, P.; Schoenherr, R. M.; Zhao, L.; Voytovich, U. J.; Kelly-Spratt, K. S.; Krasnoselsky, A.; Gafken, P. R.; Hogan, J. M.; Jones, L. A.; Wang, P.; Amon, L.; Chodosh, L. A.; Nelson, P. S.; McIntosh, M. W.; Kemp, C. J.; Paulovich, A. G. A targeted proteomics-based pipeline for verification of biomarkers in plasma Nat. Biotechnol. 2011, 29 (7) 625-634
30. Muraoka, S.; Kume, H.; Watanabe, S.; Adachi, J.; Kuwano, M.; Sato, M.; Kawasaki, N.; Kodera, Y.; Ishitobi, M.; Inaji, H.; Miyamoto, Y.; Kato, K.; Tomonaga, T. Strategy for SRM-based verification of biomarker candidates discovered by iTRAQ method in limited breast cancer tissue samples J. Proteome Res. 2012, 11 (8) 4201-4210
31. Whiteaker, J. R.; Zhang, H.; Zhao, L.; Wang, P.; Kelly-Spratt, K. S.; Ivey, R. G.; Piening, B. D.; Feng, L. C.; Kasarda, E.; Gurley, K. E.; Eng, J. K.; Chodosh, L. A.; Kemp, C. J.; McIntosh, M. W.; Paulovich, A. G. Integrated pipeline for mass spectrometry-based discovery and confirmation of biomarkers demonstrated in a mouse model of breast cancer J. Proteome Res. 2007, 6 (10) 3962-3975
32. Shaheed, S. U.; Rustogi, N.; Scally, A.; Wilson, J.; Thygesen, H.; Loizidou, M. A.; Hadjisavvas, A.; Hanby, A.; Speirs, V.; Loadman, P.; Linforth, R.; Kyriacou, K.; Sutton, C. W. Identification of stage-specific breast markers using quantitative proteomics J. Proteome Res. 2013, 12 (12) 5696-5708
33. Umar, A.; Kang, H.; Timmermans, A. M.; Look, M. P.; Meijer-van Gelder, M. E.; den Bakker, M. A.; Jaitly, N.; Martens, J. W.; Luider, T. M.; Foekens, J. A.; Pasa-Tolic, L. Identification of a putative protein profile associated with tamoxifen therapy resistance in breast cancer Mol. Cell Proteomics 2009, 8 (6) 1278-1294
34. Geiger, T.; Madden, S. F.; Gallagher, W. M.; Cox, J.; Mann, M. Proteomic portrait of human breast cancer progression identifies novel prognostic markers Cancer Res. 2012, 72 (9) 2428-2439
35. Narumi, R.; Murakami, T.; Kuga, T.; Adachi, J.; Shiromizu, T.; Muraoka, S.; Kume, H.; Kodera, Y.; Matsumoto, M.; Nakayama, K.; Miyamoto, Y.; Ishitobi, M.; Inaji, H.; Kato, K.; Tomonaga, T. A strategy for large-scale phosphoproteomics and SRM-based validation of human breast cancer tissue samples J. Proteome Res. 2012, 11 (11) 5311-5322
36. Biarc, J.; Gonzalo, P.; Mikaelian, I.; Fattet, L.; Deygas, M.; Gillet, G.; Lemoine, J.; Rimokh, R. Combination of a discovery LC-MS/MS analysis and a label-free quantification for the characterization of an epithelial-mesenchymal transition signature J. Proteomics 2014, 110, 183-194
37. Ryden, L.; Jonsson, P. E.; Chebil, G.; Dufmats, M.; Ferno, M.; Jirstrom, K.; Kallstrom, A. C.; Landberg, G.; Stal, O.; Thorstenson, S.; Nordenskjold, B. Two years of adjuvant tamoxifen in premenopausal patients with breast cancer: a randomised, controlled trial with long-term follow-up Eur. J. Cancer 2005, 41 (2) 256-264
38. Swedish Breast Cancer Cooperative Group Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer J. Natl. Cancer Inst. 1996, 88 (21) 1543-1549
39. Tian, Y.; Zhou, Y.; Elliott, S.; Aebersold, R.; Zhang, H. Solid-phase extraction of N-linked glycopeptides Nat. Protoc. 2007, 2 (2) 334-339
40. Huttenhain, R.; Surinova, S.; Ossola, R.; Sun, Z.; Campbell, D.; Cerciello, F.; Schiess, R.; Bausch-Fluck, D.; Rosenberger, G.; Chen, J.; Rinner, O.; Kusebauch, U.; Hajduch, M.; Moritz, R. L.; Wollscheid, B.; Aebersold, R. N-Glycoprotein SRMAtlas: A resource of mass spectrometric assays for N-glycosites enabling consistent and multiplexed protein quantification for clinical applications Mol. Cell Proteomics 2013, 12 (4) 1005-1016
41. Mi, H.; Muruganujan, A.; Casagrande, J. T.; Thomas, P. D. Large-scale gene function analysis with the PANTHER classification system Nat. Protoc. 2013, 8 (8) 1551-1566
42. Mi, H.; Muruganujan, A.; Thomas, P. D. PANTHER in 2013: Modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees Nucleic Acids Res. 2013, 41 (Database issue) D377-D386
43. Malmstrom, L.; Marko-Varga, G.; Westergren-Thorsson, G.; Laurell, T.; Malmstrom, J. 2DDB-A bioinformatics solution for analysis of quantitative proteomics data BMC Bioinf. 2006, 7, 158
44. Malmstrom, L.; Malmstrom, J.; Marko-Varga, G.; Westergren-Thorsson, G. Proteomic 2DE database for spot selection, automated annotation, and data analysis J. Proteome Res. 2002, 1 (2) 135-138
45. Escher, C.; Reiter, L.; MacLean, B.; Ossola, R.; Herzog, F.; Chilton, J.; MacCoss, M. J.; Rinner, O. Using iRT, a normalized retention time for more targeted measurement of peptides Proteomics 2012, 12 (8) 1111-1121
46. Reiter, L.; Rinner, O.; Picotti, P.; Huttenhain, R.; Beck, M.; Brusniak, M. Y.; Hengartner, M. O.; Aebersold, R. mProphet: Automated data processing and statistical validation for large-scale SRM experiments Nat. Methods 2011, 8 (5) 430-435
47. Gyorffy, B.; Lanczky, A.; Eklund, A. C.; Denkert, C.; Budczies, J.; Li, Q.; Szallasi, Z. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients Breast Cancer Res. Treat. 2010, 123 (3) 725-731
48. Senkus, E.; Kyriakides, S.; Penault-Llorca, F.; Poortmans, P.; Thompson, A.; Zackrisson, S.; Cardoso, F. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann. Oncol 2013, 24 (Suppl 6) vi7-23
49. Vizcaino, J. A.; Deutsch, E. W.; Wang, R.; Csordas, A.; Reisinger, F.; Rios, D.; Dianes, J. A.; Sun, Z.; Farrah, T.; Bandeira, N.; Binz, P. A.; Xenarios, I.; Eisenacher, M.; Mayer, G.; Gatto, L.; Campos, A.; Chalkley, R. J.; Kraus, H. J.; Albar, J. P.; Martinez-Bartolome, S.; Apweiler, R.; Omenn, G. S.; Martens, L.; Jones, A. R.; Hermjakob, H. ProteomeXchange provides globally coordinated proteomics data submission and dissemination Nat. Biotechnol. 2014, 32 (3) 223-226
50. Bordeaux, J.; Welsh, A.; Agarwal, S.; Killiam, E.; Baquero, M.; Hanna, J.; Anagnostou, V.; Rimm, D. Antibody validation Biotechniques 2010, 48 (3) 197-209
51. Aebersold, R.; Burlingame, A. L.; Bradshaw, R. A. Western Blots vs. SRM Assays: Time to turn the tables? Mol. Cell Proteomics 2013, 12 (9) 2381-2382
52. Addona, T. A.; Abbatiello, S. E.; Schilling, B.; Skates, S. J.; Mani, D. R.; Bunk, D. M.; Spiegelman, C. H.; Zimmerman, L. J.; Ham, A. J.; Keshishian, H.; Hall, S. C.; Allen, S.; Blackman, R. K.; Borchers, C. H.; Buck, C.; Cardasis, H. L.; Cusack, M. P.; Dodder, N. G.; Gibson, B. W.; Held, J. M.; Hiltke, T.; Jackson, A.; Johansen, E. B.; Kinsinger, C. R.; Li, J.; Mesri, M.; Neubert, T. A.; Niles, R. K.; Pulsipher, T. C.; Ransohoff, D.; Rodriguez, H.; Rudnick, P. A.; Smith, D.; Tabb, D. L.; Tegeler, T. J.; Variyath, A. M.; Vega-Montoto, L. J.; Wahlander, A.; Waldemarson, S.; Wang, M.; Whiteaker, J. R.; Zhao, L.; Anderson, N. L.; Fisher, S. J.; Liebler, D. C.; Paulovich, A. G.; Regnier, F. E.; Tempst, P.; Carr, S. A. Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma Nat. Biotechnol. 2009, 27 (7) 633-641
53. Kennedy, J. J.; Abbatiello, S. E.; Kim, K. Demonstrating the feasibility of large-scale development of standardized assays to quantify human proteins Nat. Methods 2014, 11 (2) 149-155
54. Blume-Jensen, P.; Hunter, T. Oncogenic kinase signalling Nature 2001, 411 (6835) 355-65
55. Hembrough, T.; Thyparambil, S.; Liao, W. L.; Darfler, M. M.; Abdo, J.; Bengali, K. M.; Hewitt, S. M.; Bender, R. A.; Krizman, D. B.; Burrows, J. Application of selected reaction monitoring for multiplex quantification of clinically validated biomarkers in formalin-fixed, paraffin-embedded tumor tissue J. Mol. Diagn 2013, 15 (4) 454-465
56. Schoenherr, R. M.; Whiteaker, J. R.; Zhao, L.; Ivey, R. G.; Trute, M.; Kennedy, J.; Voytovich, U. J.; Yan, P.; Lin, C.; Paulovich, A. G. Multiplexed quantification of estrogen receptor and HER2/Neu in tissue and cell lysates by peptide immunoaffinity enrichment mass spectrometry Proteomics 2012, 12 (8) 1253-1260
57. Zimmerman, A. W.; Joosten, B.; Torensma, R.; Parnes, J. R.; van Leeuwen, F. N.; Figdor, C. G. Long-term engagement of CD6 and ALCAM is essential for T-cell proliferation induced by dendritic cells Blood 2006, 107 (8) 3212-3220
58. Salgado, R.; Denkert, C.; Demaria, S.; Sirtaine, N.; Klauschen, F.; Pruneri, G.; Wienert, S.; Van den Eynden, G.; Baehne, F. L.; Penault-Llorca, F.; Perez, E. A.; Thompson, E. A.; Symmans, W. F.; Richardson, A. L.; Brock, J.; Criscitiello, C.; Bailey, H.; Ignatiadis, M.; Floris, G.; Sparano, J.; Kos, Z.; Nielsen, T.; Rimm, D. L.; Allison, K. H.; Reis-Filho, J. S.; Loibl, S.; Sotiriou, C.; Viale, G.; Badve, S.; Adams, S.; Willard-Gallo, K.; Loi, S. Harmonization of the evaluation of tumor infiltrating lymphocytes (TILs) in breast cancer: Recommendations by an international TILs-Working Group 2014 Ann. Oncol. 2015, 26 (2) 259-271
59. Tan, L. Z.; Song, Y.; Nelson, J.; Yu, Y. P.; Luo, J. H. Integrin alpha 7 Binds Tissue Inhibitor of Metalloproteinase 3 to Suppress Growth of Prostate Cancer Cells Am. J. Pathol. 2013, 183 (3) 831-840
60. Kim, S. H.; Lee, H. Y.; Jung, S. P.; Kim, S.; Lee, J. E.; Nam, S. J.; Bae, J. W. Role of secreted type I collagen derived from stromal cells in two breast cancer cell lines Oncol. Lett. 2014, 8 (2) 507-512
61. Aprile, G.; Avellini, C.; Reni, M.; Mazzer, M.; Foltran, L.; Rossi, D.; Cereda, S.; Iaiza, E.; Fasola, G.; Piga, A. Biglycan expression and clinical outcome in patients with pancreatic adenocarcinoma Tumour Biol. 2013, 34 (1) 131-137
62. Hu, L.; Duan, Y. T.; Li, J. F.; Su, L. P.; Yan, M.; Zhu, Z. G.; Liu, B. Y.; Yang, Q. M. Biglycan enhances gastric cancer invasion by activating FAK signaling pathway Oncotarget 2014, 5 (7) 1885-1896
63. Liu, Y.; Li, W.; Li, X.; Tai, Y.; Lu, Q.; Yang, N.; Jiang, J. Expression and significance of biglycan in endometrial cancer Arch Gynecol. Obstet. 2014, 289 (3) 649-655
64. Bischof, A. G.; Yuksel, D.; Mammoto, T.; Mammoto, A.; Krause, S.; Ingber, D. E. Breast cancer normalization induced by embryonic mesenchyme is mediated by extracellular matrix biglycan Integr. Biol. 2013, 5 (8) 1045-1056
65. Batlle, E.; Bacani, J.; Begthel, H.; Jonkheer, S.; Gregorieff, A.; van de Born, M.; Malats, N.; Sancho, E.; Boon, E.; Pawson, T.; Gallinger, S.; Pals, S.; Clevers, H. EphB receptor activity suppresses colorectal cancer progression Nature 2005, 435 (7045) 1126-1130
66. Soto, M. S.; Serres, S.; Anthony, D. C.; Sibson, N. R. Functional role of endothelial adhesion molecules in the early stages of brain metastasis Neuro-Oncology 2014, 16 (4) 540-551
67. Guo, P.; Huang, J.; Wang, L.; Jia, D.; Yang, J.; Dillon, D. A.; Zurakowski, D.; Mao, H.; Moses, M. A.; Auguste, D. T. ICAM-1 as a molecular target for triple negative breast cancer Proc. Natl. Acad. Sci. U. S. A. 2014, 111 (41) 14710-14715
68. Bauer, K. M.; Watts, T. N.; Buechler, S.; Hummon, A. B. Proteomic and Functional Investigation of the Colon Cancer Relapse-Associated Genes NOX4 and ITGA3 J. Proteome Res. 2014, 13 (11) 4910-4918
69. Ren, Y.; Hao, P.; Law, S. K.; Sze, S. K. Hypoxia-induced Changes to Integrin alpha 3 Glycosylation Facilitate Invasion in Epidermoid Carcinoma Cell Line A431 Mol. Cell Proteomics 2014, 13 (11) 3126-3137
70. Wang, Y.; Ao, X.; Vuong, H.; Konanur, M.; Miller, F. R.; Goodison, S.; Lubman, D. M. Membrane glycoproteins associated with breast tumor cell progression identified by a lectin affinity approach J. Proteome Res. 2008, 7 (10) 4313-4325
71. Pasini, F. S.; Maistro, S.; Snitcovsky, I.; Barbeta, L. P.; Rotea Mangone, F. R.; Lehn, C. N.; Walder, F.; Carvalho, M. B.; Brentani, M. M.; Federico, M. H. Four-gene expression model predictive of lymph node metastases in oral squamous cell carcinoma Acta Oncol. 2012, 51 (1) 77-85
72. Khan, S. A.; Rogers, M. A.; Obando, J. A.; Tamsen, A. Estrogen receptor expression of benign breast epithelium and its association with breast cancer Cancer Res. 1994, 54 (4) 993-997